胆固醇用于心血管事件的二次预防
Fahim Ebrahimi1,2, Ramin Ebrahimi3,4, Maximilian Beer5
1Department of Gastroenterology and Hepatology, University Digestive Health Care Center Basel - Clarunis, Switzerland, Basel, Switzerland.
The Cochrane database of systematic reviews
|November 12, 2025
概括
低剂量的胆固醇可显著降低心肌梗塞和中风风险在心血管疾病患者. 虽然通常是安全的,但它增加了胃肠道问题,对死亡率没有明显的影响.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 炎症研究 炎症研究
背景情况:
- 心血管疾病 (CVD) 患者面临复发事件的高风险.
- 慢性低度炎症是心血管疾病进展的关键因素.
- 低剂量胆固醇正在探索二次心血管疾病预防.
研究的目的:
- 评价低剂量胆固醇对预防心血管事件的益处和危害.
- 评估科尔奇辛在有稳定心血管疾病,心肌梗塞或中风病史的患者中的疗效.
主要方法:
- 随机对照试验 (RCT) 的系统审查和元分析.
- 包括12个RCT与22,983名参与者,比较低剂量胆固醇 (每天0.5毫克) 与对照.
- 评估结果包括死亡率,心肌梗塞,中风和使用GRADE确定性评估的不良事件.
主要成果:
- 高确定性证据显示,用素降低了心肌梗塞 (RR 0.74) 和中风 (RR 0.67) 的风险.
- 没有发现严重不良事件的增加 (RR 0.98).
- 增加了胃肠道不良事件 (RR 1.68);死亡率和再血管化显示中等确定性证据没有显著差异.
结论:
- 低剂量胆固醇在降低心肌梗塞和中风患者心血管疾病患者的显著益处.
- 治疗与胃肠道副作用的增加有关,但没有严重的不良事件.
- 对于特定的患者亚组和适用症需要进行进一步的研究.
相关概念视频
Coronary Artery Disease IV: Preventive Measures
578
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
578
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Coronary Artery Disease V: Interprofessional Care
207
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
207
Atherosclerosis III: Management
307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Rheumatic Heart Disease III: Medical Management
272
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
272
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K

